Cargando…
No differences in metabolic outcomes between nadir GH 0.4 and 1.0 ng/mL during OGTT in surgically cured acromegalic patients (observational study)
Metabolic impairment is the common cause for mortality in acromegalic patients. In this study, long-term improvements of metabolic parameters were evaluated according to 2 different remission criteria. This was an observational cohort study before and up to 1 year after transsphenoidal adenomectomy...
Autores principales: | Ku, Cheol Ryong, Choe, Eun Yeong, Hong, Jae Won, Kim, Eui Hyun, Park, Se Hee, Kim, Sun Ho, Lee, Eun Jig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998443/ https://www.ncbi.nlm.nih.gov/pubmed/27310957 http://dx.doi.org/10.1097/MD.0000000000003808 |
Ejemplares similares
-
Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious Diseases
por: Lee, Woo Kyung, et al.
Publicado: (2016) -
MON-436 Clinical Phenotypes of GNAS Gene Mutations in Acromegalic Patients
por: Jung, Hyein, et al.
Publicado: (2019) -
Long-term follow-up of patients with elevated IGF-1 and nadir GH > 0.4 µg/L but < 1 µg/L
por: Rosario, Pedro Weslley, et al.
Publicado: (2017) -
GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers
por: Lee, Jandee, et al.
Publicado: (2015) -
Aberrant Expression of COT Is Related to Recurrence of Papillary Thyroid Cancer
por: Lee, Jandee, et al.
Publicado: (2015)